Shoulder PainNCT07062679
Maitland Vs Mulligan Mobilization in Patients With Shoulder Pain
A study testing Maitland Oscillatory Glides/Mobilization and Mulligan Mobilization with Movement (MWM) in people with Shoulder Pain, run by Riphah International University at 1 site in Pakistan.
Trial summary
To find the effect of the Maitland Mobilization versus Mulligans Mobilization on the pain of the patient suffering from Shoulder pain. To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the functional status of the patient suffering from shoulder pain. Read more about this study
- Who is it for?
- Ages 3 months to 1 year
- Conditions the study is for
- Shoulder Pain
- What is being tested?
- Maitland Oscillatory Glides/Mobilization and Mulligan Mobilization with Movement (MWM)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 sitePakistan
- Study dates
- 15 Jul 2025to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 months to 1 year
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Shoulder pain from last 3 months to 1 year, Male and Female patients will be included \& Age 20 years to 60 years.
Who cannot join
- Pain more than 1 year, Patients with certain shoulder structural deformities \& Patients with autoimmune disease.
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Saidu Group of Teaching Hospital Mingora Swat
Swāt, KPK, 19200
About this study
Official title: Effectiveness of Maitland Vs Mulligan Mobilization in Patient With Shoulder Pain
- To find the effect of the Maitland Mobilization versus Mulligans Mobilization on the pain of the patient suffering from Shoulder pain.
- To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the functional status of the patient suffering from shoulder pain.
- To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the psychological health status of that patient.
Read the detailed description
Shoulder is the most movable joint in the human body. A group of four muscles and their tendons, called the rotator cuff, give the shoulder its wide range of motion Rotator cuff muscles Swelling, damage, or bone changes around the rotator cuff can cause shoulder pain. Shoulder pain is highly prevalent and among musculoskeletal disorders is the third most common reason for visiting a primary care physician
- Conditions
- Shoulder Pain
- Being tested
- Maitland Oscillatory Glides/Mobilization, Mulligan Mobilization with Movement (MWM)
- Keywords
- Pain, Functional Status, Psychological Health Status
- Medical subject headings
- Shoulder Pain, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Maitland Oscillatory Glides/MobilizationOther
Hot pack for 15 minutes Ultrasound for 5 minutes Maitland Mobilization Oscillatory Glides inferiorly during normal abduction. Glenohumeral caudal glide mobilization was given at the rate of 2-3 glides per second for 30 seconds for each glide, 5 sets were given.
(3 sessions per week for 4 weeks)
Mulligan Mobilization with Movement (MWM)Other
Hot pack for 15 minutes Ultrasound for 5 minutes Mobilization with Movement (MWM) Patient sitting with therapist posterolateral to him/her. Therapist places the Mulligan belt across the humeral head and to his waist. Patient movement (Flexion, extension, \& abduction respectively) combined with therapist-applied joint gliding (postero-lateral Glide) MWM will be performed.
3 sets of 10 reps per session (30 seconds rest between sets)
(3 sessions per week for 4 weeks)
| Study group | Role | What they receive |
|---|---|---|
| Group A | Experimental | Maitland Mobilization Oscillatory Glides Receives: Other: Maitland Oscillatory Glides/Mobilization |
| Group B | Experimental | Mulligan Mobilization with Movement (MWM) Receives: Other: Mulligan Mobilization with Movement (MWM) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Shoulder Pain Intensity Measured by Numeric Pain Rating Scale (NPRS)
The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable") High test-retest reliability has been observed in both literate and illiterate patients with rheumatoid arthritis (r = 0.96 and 0.95, respectively) before and after medical consultation.
Measured: 4 Weeks
Shoulder Disability Level Measured by DASH (Disability of the Arm Shoulder and Hand Questionnaire)
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
Measured: 4 Weeks
Psychological Status Measured by Beck Depression Inventory Score
The Beck Depression Inventory (BDI) is a 21-item questionnaire used to assess the severity of depressive symptoms. Scores range from 0 to 63, with higher scores indicating more severe symptoms. Interpretation of scores generally follows these guidelines: 0-13: minimal depression, 14-19: mild depression, 20-28: moderate depression, and 29-63: severe depression.
Measured: 4 Weeks
Cognitive & Emotional Response to Pain Measured by Pain Catastrophic Scale
The Pain Catastrophizing Scale (PCS) is a 13-item self-report questionnaire that measures an individual's negative cognitive and emotional responses to pain.
Measured: 4 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jul 2025
- Study start15 Jul 2025
- Primary completion3 Oct 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Shoulder PainStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 46 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ayesha Sadiq, MSPT (OMPT), Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07062679
- Sponsor's protocol ID
- REC-01011 Shah Alam Khan
- Status last verified
- Feb 2026
- First submitted
- 3 Jul 2025
- Last updated
- 25 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Maitland Vs Mulligan Mobilization in Patient With Shoulder Pain
- ClinicalTrials.gov ID
- NCT07062679
- Acronym / sponsor ID
- REC-01011 Shah Alam Khan
- Conditions
- Shoulder Pain
- Keywords
- Pain, Functional Status, Psychological Health Status
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 46 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 15 Jul 2025 (actual)
- Primary completion
- 3 Oct 2025 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 14 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- To find the effect of the Maitland Mobilization versus Mulligans Mobilization on the pain of the patient suffering from Shoulder pain.
- To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the functional status of the patient suffering from shoulder pain.
- To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the psychological health status of that patient.
Detailed description
Shoulder is the most movable joint in the human body. A group of four muscles and their tendons, called the rotator cuff, give the shoulder its wide range of motion Rotator cuff muscles Swelling, damage, or bone changes around the rotator cuff can cause shoulder pain. Shoulder pain is highly prevalent and among musculoskeletal disorders is the third most common reason for visiting a primary care physician
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A | Experimental | Other: Maitland Oscillatory Glides/MobilizationMaitland Mobilization Oscillatory Glides |
| Group B | Experimental | Other: Mulligan Mobilization with Movement (MWM)Mulligan Mobilization with Movement (MWM) |
Who may qualify
- Ages
- 3 months to 1 year
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Shoulder pain from last 3 months to 1 year, Male and Female patients will be included \& Age 20 years to 60 years.
Key exclusion criteria (1 listed)
- Pain more than 1 year, Patients with certain shoulder structural deformities \& Patients with autoimmune disease.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Maitland Oscillatory Glides/MobilizationHot pack for 15 minutes Ultrasound for 5 minutes Maitland Mobilization Oscillatory Glides inferiorly during normal abduction. Glenohumeral caudal glide mobilization was given at the rate of 2-3 glides per second for 30 seconds for each glide, 5 sets were given. (3 sessions per week for 4 weeks) | Other | Group A |
| Mulligan Mobilization with Movement (MWM)Hot pack for 15 minutes Ultrasound for 5 minutes Mobilization with Movement (MWM) Patient sitting with therapist posterolateral to him/her. Therapist places the Mulligan belt across the humeral head and to his waist. Patient movement (Flexion, extension, \& abduction respectively) combined with therapist-applied joint gliding (postero-lateral Glide) MWM will be performed. 3 sets of 10 reps per session (30 seconds rest between sets) (3 sessions per week for 4 weeks) | Other | Group B |
Primary outcome
Change in Shoulder Pain Intensity Measured by Numeric Pain Rating Scale (NPRS)
Time frame: 4 Weeks
The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable") High test-retest reliability has been observed in both literate and illiterate patients with rheumatoid arthritis (r = 0.96 and 0.95, respectively) before and after medical consultation.
Shoulder Disability Level Measured by DASH (Disability of the Arm Shoulder and Hand Questionnaire)
Time frame: 4 Weeks
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
Psychological Status Measured by Beck Depression Inventory Score
Time frame: 4 Weeks
The Beck Depression Inventory (BDI) is a 21-item questionnaire used to assess the severity of depressive symptoms. Scores range from 0 to 63, with higher scores indicating more severe symptoms. Interpretation of scores generally follows these guidelines: 0-13: minimal depression, 14-19: mild depression, 20-28: moderate depression, and 29-63: severe depression.
Cognitive & Emotional Response to Pain Measured by Pain Catastrophic Scale
Time frame: 4 Weeks
The Pain Catastrophizing Scale (PCS) is a 13-item self-report questionnaire that measures an individual's negative cognitive and emotional responses to pain.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2026.
Related trials for Shoulder Pain
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Recruiting
Hybrid mHealth and Telerehabilitation vs Conventional Physiotherapy for Subacromial Pain Syndrome
Subacromial Pain Syndrome
Not yet recruiting
Magnesium Sulphate as an Adjuvant in Combined Costoclavicular Block and Suprascapular Block Versus Interscalene Block for Ambulatory Shoulder Arthroscopy
Postoperative Pain, Shoulder Arthroscopy
Active, not recruiting
Effects of Injection Combined With Spencer Technique on Painful Frozen Shoulder
Frozen Shoulder
Not yet recruiting
Laser Therapy Versus Transcutaneous Electical Nerve Stimulation at Hemiplegic Shoulder Pain
Hemiplegic Shoulder Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ayesha Sadiq, MSPT (OMPT) principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Maitland Oscillatory Glides/Mobilization and Mulligan Mobilization with Movement (MWM) in people with Shoulder Pain, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Shoulder Pain Intensity Measured by Numeric Pain Rating Scale (NPRS) (time frame: 4 Weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.